“Certolizumab Pegol for the Treatment of Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Overview of 3 Randomized Controlled Trials”, J of Skin, vol. 2, no. S1, p. S3, Feb. 2018, doi: 10.25251/skin.2.supp.3.